News and Announcements
Anti-Cancer Drug Discovered in Rainforest Successfully Tested on Humans
- Published August 23, 2016 11:01AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd August 2016, The Cairns Post by Daniel Bateman
A POTENTIAL cancer cure discovered in Far North Queensland that has been successfully tested on human patients is hoped to become commercially available in four years.
Brisbane-based researchers QBiotics have released the results of their first clinical trials of the drug EBC-46.
The drug has been derived from the seeds of the rainforest blushwood tree, which grows on the Tablelands.
Eight cancer patients across Australia were tested with the drug, which successfully treated four different types of tumours that included melanoma, squamous cell carcinoma, basal cell carcinoma, and breast adenocarcinoma.
QBiotics CEO Dr Victoria Gordon said none of the patients, who were treated at hospitals in Brisbane, Sydney, Melbourne and Adelaide, showed any negative side effects from the drug.
“Our last patient – which was our melanoma patient – we had total tumour destruction in both of the tumours that we treated,” she said.
“We’re very happy about that.
“Within seven days, the tumours were gone.
“The exciting thing is the drugs are responding in exactly the same way in tumours in cats and dogs and horses.
“It’s proving our theory that it’s not species-specific, and it’s not tumour-specific either, because it’s actually working in a range of tumours.”
To read the full article, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
